First-line cemiplimab for locally advanced non-small cell lung cancer: Updated subgroup analyses from EMPOWER-Lung 1 and EMPOWER-Lung 3 için istatistikler
Toplam ziyaret
views | |
---|---|
First-line cemiplimab for locally advanced non-small cell lung cancer: Updated subgroup analyses from EMPOWER-Lung 1 and EMPOWER-Lung 3 | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ocak 2024 | 0 |
Şubat 2024 | 0 |
Mart 2024 | 0 |
Nisan 2024 | 0 |
Mayıs 2024 | 0 |
Haziran 2024 | 0 |
Temmuz 2024 | 0 |